AAAAAA
Results:
1-14
|
Results: 14
Authors:
HENZE G
BORGMANN A
VONSTACKELBERG A
BAUMGARTEN E
UCHANSKAZIEGLER B
ZIEGLER A
WITTIG B
Citation: G. Henze et al., IMMUNOTHERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA BY VACCINATION WITH AUTOLOGOUS LEUKEMIC-CELLS TRANSFECTED WITH A CDNA EXPRESSION PLASMID CODING FOR AN ALLOGENEIC HLA CLASS-I ANTIGEN COMBINED WITH INTERLEUKIN-2 TREATMENT, Journal of molecular medicine, 76(3-4), 1998, pp. 215-221
Authors:
BORGMANN A
BAUMGARTEN E
SCHMID H
DOPFER R
EBELL W
GOBEL U
NIETHAMMER D
GADNER H
HENZE G
Citation: A. Borgmann et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR A SUBSET OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN 3RD REMISSION - A CONCEIVABLE ALTERNATIVE, Bone marrow transplantation, 20(11), 1997, pp. 939-944
Authors:
ODLAND LM
MACDOUGALL JD
TARNOPOLSKY MA
ELORRIAGA A
BORGMANN A
Citation: Lm. Odland et al., EFFECT OF ORAL CREATINE SUPPLEMENTATION ON MUSCLE [PCR] AND SHORT-TERM MAXIMUM POWER OUTPUT, Medicine and science in sports and exercise, 29(2), 1997, pp. 216-219
Authors:
BORGMANN A
Citation: A. Borgmann, TECHNOLOGY AND THE CRISIS OF CONTEMPORARY CULTURE + CROSSING THE POSTMODERN DIVIDE BETWEEN MODERN SOCIETY AND RELIGION, American Catholic philosophical quarterly, 70, 1996, pp. 33-44
Authors:
SCHMID H
VONSCHENCK U
HARTMANN R
BORGMANN A
HENZE G
Citation: H. Schmid et al., ALLOGENEIC BMT VS CHEMOTHERAPY IN LATE BONE-MARROW RELAPSED CHILDHOODNON-T NON-B ALL - RESULTS OF BFM-ALL RELAPSE STUDIES/, Bone marrow transplantation, 18, 1996, pp. 28-30
Authors:
BORGMANN A
Citation: A. Borgmann, INFORMATION AND REALITY AT THE TURN-OF-THE-CENTURY, Design issues, 11(2), 1995, pp. 21-30
Authors:
BORGMANN A
Citation: A. Borgmann, THE CAMBRIDGE COMPANION TO HEIDEGGER - GUIGNON,C, The Journal of English and Germanic philology, 94(2), 1995, pp. 306-307
Authors:
BORGMANN A
HARTMANN R
SCHMID H
KLINGEBIEL T
EBELL W
GOBEL U
PETERS C
GADNER H
HENZE G
Citation: A. Borgmann et al., ISOLATED EXTRAMEDULLARY RELAPSE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - A COMPARISON BETWEEN TREATMENT RESULTS OF CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(4), 1995, pp. 515-521
Authors:
BORGMANN A
Citation: A. Borgmann, DOES PHILOSOPHY MATTER, Technology in society, 17(3), 1995, pp. 295-309
Authors:
BORGMANN A
SCHMID H
HARTMANN R
BAUMGARTEN E
HERMANN K
KLINGEBIEL T
EBELL W
ZINTL F
GADNER H
HENZE G
Citation: A. Borgmann et al., AUTOLOGOUS BONE-MARROW TRANSPLANTS COMPARED WITH CHEMOTHERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN A 2ND REMISSION - A MATCHED-PAIR ANALYSIS, Lancet, 346(8979), 1995, pp. 873-876
Authors:
BORGMANN A
Citation: A. Borgmann, THEORY, PRACTICE, REALITY + REPLY TO SPINOSA, FLORES, AND DREYFUS, Inquiry, 38(1-2), 1995, pp. 143-156
Authors:
BORGMANN A
EMMINGER W
EMMINGERSCHMIDMEIER W
PETERS C
GATTERERMENZ I
HENZE G
GADNER H
Citation: A. Borgmann et al., INFLUENCE OF FRACTIONATED TOTAL-BODY IRRADIATION ON MUCOSAL TOXICITY IN INTENSIFIED CONDITIONING REGIMENS FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PEDIATRIC CANCER-PATIENTS, Klinische Padiatrie, 206(4), 1994, pp. 299-302
Authors:
SHERRY JP
BORGMANN A
Citation: Jp. Sherry et A. Borgmann, ENZYME-IMMUNOASSAY TECHNIQUES FOR THE DETECTION OF ATRAZINE IN WATER SAMPLES - EVALUATION OF A COMMERCIAL TUBE BASED ASSAY, Chemosphere, 26(12), 1993, pp. 2173-2184
Authors:
SCHMID H
HENZE G
BORGMANN A
KIRSCH A
SAUBERLICH S
SONNTAG S
SIEGERT W
HUHN D
SCHWERDTFEGER R
Citation: H. Schmid et al., HIGH-DOSE BUSULFAN (BU), VP-16(VP), AND THIOTEPA (TT) AS PREPARATIVE REGIMEN FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN HIGH-RISKALL NHL - A PHASE-II STUDY, Blood, 82(10), 1993, pp. 10000080-10000080
Risultati:
1-14
|